Metabolic effects of the combination of furosemide and captopril in rat
Article Sidebar
20)How to Cite
59
Abstract
Diuretics typically provoke increased serum lipid levels and may provoke increased serum uric acid levels and/or glucose intolerance. Furosemide is widely used as an antihypertensive, but in patients for whom furosemide treatment alone
proves insufficient to reduce hypertension, a common procedure is to co-administer the angiotensin-converting-enzyme (ACE) inhibitor captopril. The metabolic effects in rats of joint administration of furosemide (15 mg/kg/day) and captopril
(2 mg/kg/day) are evaluated over a two-week period. At the end of this period, the serum levels of lipids, uric acid, bilirubin, proteins and various enzymes were determined as well as the effect of the treatment on intestinal absorption of glucose and calcium. Furosemide/captopril led to an increase in serum albumin and alkaline phosphatase levels, and a decrease in triglyceride levels. The results of this work support the view that this drug combination is suitable for hypertension treatment.
Authors
References
Ambrosini, E., Borghi, C. and Costa, V. (1987): Br.J. Clin. Pharmacol, 23, 43-50. https://doi.org/10.1111/j.1365-2125.1987.tb03121.x
Ames, R. P. and Hill, P. (1982): J. Cardiovasc.Pharmacol, 4, 206-212.
Ames, R. P. (1983): Ara. Heart J., 106, 1207- 1214. https://doi.org/10.1016/0002-8703(83)90176-X
Ames, R. P. and Peacock, P. (1994): Arch. Intern. Med., 144, 710-714. https://doi.org/10.1001/archinte.144.4.710
Barba, G., Strazullo, P., Galleti, A. S., Di Carlo, A. and Mancini, M. (1992): Cnrr. Ther. Res., 52, 524-531. https://doi.org/10.1016/S0011-393X(05)80458-8
Bianchi, S., Bigazzi, R., Baldiri, G., and Campese, V. (1992): Am. J. Med., 93, 525-528. https://doi.org/10.1016/0002-9343(92)90580-5
Bushinsky, D., Favus, M., Langman, B. and Coef, L. (1986): Am. J. Physiol, 251, F17-F24. https://doi.org/10.1152/ajprenal.1986.251.1.F17
Buzio, C., Rcgolisti, G., Perazzoli, F., Bergamascchi, E. and Borghetti, A. (1994): Hypertension, 24, 763-769. https://doi.org/10.1161/01.HYP.24.6.763
Chrysant, S. G., Brown, R. D., Kem, D., and Brown, J. L. (1983): Clin. Pharmacol. Ther., 33, 741-746. https://doi.org/10.1038/clpt.1983.101
Erley, C. M., Haefele, U., Heyne, N., Braun, N. and Risler, T. (1993): Hypertension, 21, 810-815. https://doi.org/10.1161/01.HYP.21.6.810
Griffing, G. T. and Melby, J. C. (1982): Ctirr.Ther. Res., 32, 396-405. https://doi.org/10.1038/clpt.1982.208
Joos, C., Kewitz, H. and Reinhold-Kourniati, D. (1980): Enr. J. Clin. Pharmacol, 17, 251-257. https://doi.org/10.1007/BF00625798
Keller, U., Weiss, M. and Stauffacher, W. (1989): Diabetes, 38, 454-459. https://doi.org/10.2337/diabetes.38.4.454
Koffer, H., Vlasses, P. H., Ferguson, R. K., Weis, M. and Adler, A. G. (1980): JAMA, 244, 2532-2535. https://doi.org/10.1001/jama.244.22.2532
Lasser, N. L., Grandits, G. and Caggiula, A.W.(1984): Am. J. Med., 27, 52-66. https://doi.org/10.1016/0002-9343(84)90957-4
Levy, B. (1977): J. Clin. Pharmacol, 34, 420- 430. https://doi.org/10.1002/j.1552-4604.1977.tb04625.x
Lithell, H. (1991): Diabetes Care, 14, 203-209. https://doi.org/10.2337/diacare.14.3.203
Malini, P. L., Strocchi, E., Ambrosini, E. and Magnani, B. (1984): J. Hypertens., 2, 101-105.
Middlemost, S. J., Tager, R., Davis, J. and Sarcli, P. (1994): Am. J. Cardiol, 73, 1092-1097. https://doi.org/10.1016/0002-9149(94)90289-5
Okssa, A., Stefikova, V., Fedelesova, V., Baculakova, V., Spustova, V. and Dzurik, R. (1992): Cor. Vasa, 34, 329-431.
Perola, P., Lehto, H., Lammintausta, R. and Viikari, J. (1985): Curr. Ther. Res., 37, 545-553.
Ponz, F., Ilundain, A. and Lluch, M. (1979): Rev. esp. Fisiol, 35, 97-104.
Pors Nielsen, S., Andersen, O. and Steven, K. E. (1969): Acta Pharmacol Toxicol, 27, 469-479. https://doi.org/10.1111/j.1600-0773.1969.tb00495.x
Prichard, B. N., Owens, W. I. and Woolf, A. S. (1992): Eur. Heart J., 13, 96-103. https://doi.org/10.1093/eurheartj/13.suppl_G.96
Sica, D. (1994): Drugs, 48, 17-24. https://doi.org/10.2165/00003495-199448010-00003
Scott, J. and Higgens, C. (1992): Ann. Rheti. Dis., 51,259-261. https://doi.org/10.1136/ard.51.2.259
Townsend, R. and Holland, B. (1990): Arch. Intern. Med., 150, 1175-1183. https://doi.org/10.1001/archinte.150.6.1175
Warshaw, B. L., Anand, S. K., Kerian, A. and Lieberman, J. (1980): Pediatr. Res., 14, 1118- 1121. https://doi.org/10.1203/00006450-198010000-00006
Weidman, P., Beretta-Picoli, C., Meier, A., Keusch, G., Gluck, Z. and Ziegler, W. H. (1983): Kidney Intern., 23, 320-326. https://doi.org/10.1038/ki.1983.22
Weidman, P., Courten, M. and Ferrari, P. (1992): Eur. Heart J., 13, 61-67. https://doi.org/10.1093/eurheartj/13.suppl_G.61
Winberger, M. H. (1983): Hypertension, 5, 132- 138.
Youssef, S., Osman, L. and Sabour, M. S. (1992): Int.J. Clin. Pharm. Res., 12, 109-116
Metrics
|
|